11 Most Popular AI Penny Stocks to Buy Now

Page 8 of 10

3. Recursion Pharmaceuticals Inc. (NASDAQ:RXRX)

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is one of the 11 most popular AI penny stocks to buy now.

On February 25, Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) reported Q4 revenue of $35.5 million compared to the consensus estimates of $24.6 million. The company’s cash, cash equivalents, and restricted cash balance totaled $753.9 million as of December 31, compared with $603 million as of the end of last year.

The company’s cash runway is expected to extend into early 2028 based on current operating plans without the need for additional financing. CEO & President Najat Khan said the company has now reached an inflection point where the organization is no longer just proving the role of AI in drug discovery but is now proving the clinical proof and long-term value of an AI-native operating system. The fact that this is the first AI-enabled clinical proof of concept in FAP, along with the fact that this is the fifth Sanofi program milestone, shows the maturity of the model.

The company is entering 2026 with five clinical programs advancing, a growing discovery portfolio, and over $500 million earned in upfront and milestone payments.

Recursion Pharmaceuticals Inc. (NASDAQ:RXRX) is a clinical-stage biotechnology company engaged in the acceleration of drug discovery by bringing together automated biology, data science, machine learning, and high-performance computing. Some of its offerings include REC-4881, REC-617, REC-1245, REC-3565, and REC-4539.

Page 8 of 10